Clinical role of beta-lactam/beta-lactamase inhibitor combinations (Q35166387)

6 August 2017

1 reference

title

Clinical role of beta-lactam/beta-lactamase inhibitor combinations (English)

1 reference

6 August 2017

Kwok-Yung Yuen

2

1 reference

ORCID Public Data File 2021

author name string

Nelson Lee

series ordinal

1

1 reference

6 August 2017

Cyrus R Kumana

series ordinal

3

1 reference

6 August 2017

publication date

1 January 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

63

1 reference

6 August 2017

issue

14

1 reference

6 August 2017

page(s)

1511-1524

1 reference

Piperacillin-tazobactam versus imipenem-cilastatin for treatment of intra-abdominal infections

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363140-00006

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Tre

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363140-00006

Cost-effectiveness of ampicillin/sulbactam versus imipenem/cilastatin in the treatment of limb-threatening foot infections in diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363140-00006

Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363140-00006

Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363140-00006

Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00003495-200363140-00006

Practice guidelines for the management of community-acquired pneumonia in adults. Infectious Diseases Society of America

21 January 2018

1 reference

12 December 2020

Effect of beta-lactamase inhibitors on beta-lactamases from anaerobic bacteria

1 reference

12 December 2020

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

12 December 2020

In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.

1 reference

12 December 2020

Broad-spectrum beta-lactam antibiotics with beta-lactamase inhibitors

1 reference

12 December 2020

Prospective randomized comparison of imipenem-cilastatin and piperacillin-tazobactam in nosocomial pneumonia or peritonitis

1 reference

12 December 2020

Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin

1 reference

12 December 2020

Treatment options for extended-spectrum beta-lactamase-producers

1 reference

12 December 2020

Bacteriologic analysis of infected dog and cat bites. Emergency Medicine Animal Bite Infection Study Group

1 reference

12 December 2020

Pharmacokinetic properties of beta-lactamase inhibitors.

1 reference

12 December 2020

Ampicillin/sulbactam and cefoxitin in the treatment of cutaneous and other soft-tissue abscesses in patients with or without histories of injection drug abuse

1 reference

12 December 2020

Penicillin-resistant Streptococcus pneumoniae: selection by both beta-lactam and non-beta-lactam antibiotics

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of oral beta-lactam antibiotics as a two-dimensional approach to their efficacy

1 reference

12 December 2020

Clinical aspects of antimicrobial resistance

1 reference

12 December 2020

Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia

1 reference

12 December 2020

Pharmacoeconomic analysis of selected antibiotics in lower respiratory tract infection

1 reference

12 December 2020

Prevention and management of infections in patients without a spleen

1 reference

12 December 2020

Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam

1 reference

12 December 2020

Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum beta-lactamases.

1 reference

12 December 2020

The future--can we learn from the past?

1 reference

12 December 2020

Diagnosis and management of group A streptococcal pharyngitis: a practice guideline. Infectious Diseases Society of America

1 reference

12 December 2020

Multicenter survey of the changing in vitro antimicrobial susceptibilities of clinical isolates of Bacteroides fragilis group, Prevotella, Fusobacterium, Porphyromonas, and Peptostreptococcus species

1 reference

12 December 2020

Association between antibiotic resistance and community prescribing: a critical review of bias and confounding in published studies

1 reference

12 December 2020

Efficacy of sulbactam alone and in combination with ampicillin in nosocomial infections caused by multiresistant Acinetobacter baumannii

1 reference

12 December 2020

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

12 December 2020

Bactericidal action of ampicillin/sulbactam against intracellular mycobacteria

1 reference

12 December 2020

Worldwide clinical experience with sultamicillin

1 reference

12 December 2020

The control of hyperendemic glycopeptide-resistant Enterococcus spp. on a haematology unit by changing antibiotic usage

1 reference

12 December 2020

Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study

1 reference

12 December 2020

Carbapenem derivatives as potential inhibitors of various beta-lactamases, including class B metallo-beta-lactamases.

1 reference

12 December 2020

Risk factors for recovery of ampicillin-sulbactam-resistant Escherichia coli in hospitalized patients

1 reference

12 December 2020

Comparison of ampicillin-sulbactam and ticarcillin-clavulanic acid in patients with chronic renal failure: effects of differential pharmacokinetics on serum bactericidal activity.

1 reference

12 December 2020

Detection of beta-lactamase-mediated resistance

1 reference

12 December 2020

Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants

1 reference

12 December 2020

Effects of Tazobactam on the Frequency of the Emergence of Resistant Strains from Enterobacter cloacae, Citrobacter freundii, and Proteus vulgaris (.BETA.-Lactamase Derepressed Mutants)

1 reference

12 December 2020

Does the dose matter?

1 reference

12 December 2020

Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999.

1 reference

12 December 2020

1 reference

12 December 2020

Fever and neutropenia--how to use a new treatment strategy

1 reference

12 December 2020

beta-Lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone

1 reference

12 December 2020

Randomized comparison of sulbactam/cefoperazone with imipenem as empirical monotherapy for febrile granulocytopenic patients

1 reference

12 December 2020

Recommendation for treatment of severe infections caused by Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs).

1 reference

12 December 2020

Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes

1 reference

12 December 2020

Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins

1 reference

12 December 2020

Inhibitor-resistant TEM beta-lactamases: phenotypic, genetic and biochemical characteristics

1 reference

12 December 2020

Treatment of ventilator-associated pneumonia with piperacillin-tazobactam/amikacin versus ceftazidime/amikacin: a multicenter, randomized controlled trial. VAP Study Group

1 reference

12 December 2020

Current guidelines for the treatment and prevention of nosocomial infections

1 reference

12 December 2020

Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis

1 reference

12 December 2020

Incidence of beta-lactamase production and antimicrobial susceptibility of anaerobic gram-negative rods isolated from pus specimens of orofacial odontogenic infections

1 reference

12 December 2020

Mechanism of suppression of piperacillin resistance in enterobacteria by tazobactam

1 reference

12 December 2020

In-vitro susceptibilities of species of the Bacteroides fragilis group to newer beta-lactam agents.

1 reference

12 December 2020

Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication

1 reference

12 December 2020

Antibacterial activity of oral antibiotics against community-acquired respiratory pathogens from three European countries

1 reference

12 December 2020

Effect of antimicrobial agents on the ecological balance of human microflora

1 reference

12 December 2020

Extended-spectrum plasmid-mediated beta-lactamases

1 reference

12 December 2020

Burkholderia pseudomallei: the unbeatable foe?

1 reference

12 December 2020

Infection in the intensive care unit: beta-lactamase-mediated resistance among Enterobacteriaceae and optimal antimicrobial dosing.

1 reference

12 December 2020

Characterization of the inoculum effect with Haemophilus influenzae and beta-lactams

1 reference

12 December 2020

Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa

1 reference

12 December 2020

Prospective study of the risk of Clostridium difficile diarrhoea in elderly patients following treatment with cefotaxime or piperacillin-tazobactam

1 reference

12 December 2020

Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital

1 reference

12 December 2020

Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)

1 reference

12 December 2020

Genes and spectrum: the theoretical limits

1 reference

12 December 2020

Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group

1 reference

12 December 2020

Do guidelines for community-acquired pneumonia improve the cost-effectiveness of hospital care?

1 reference

12 December 2020

Clinical presentations of soft-tissue infections and surgical site infections

1 reference

12 December 2020

Comparison of concentrations of sulbactam-ampicillin administered by bolus injections or bolus plus continuous infusion in tissues of patients undergoing colorectal surgery

1 reference

12 December 2020

Hospital antibiotic prescribing successfully modified by 'immediate concurrent feedback'

1 reference

12 December 2020

Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial

1 reference

12 December 2020

A review of the role of antibiotic policies in the control of antibiotic resistance

1 reference

12 December 2020

Assessing cost effectiveness of antimicrobial treatment: monotherapy compared with combination therapy

1 reference

12 December 2020

New beta-lactamases in gram-negative bacteria: diversity and impact on the selection of antimicrobial therapy

1 reference

12 December 2020

Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases

1 reference

12 December 2020

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

1 reference

12 December 2020

Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

10.2165/00003495-200363140-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

6 August 2017

1031886568

0 references

1 reference